Genomic frontiers in congenital heart disease

SU Morton, D Quiat, JG Seidman… - Nature Reviews …, 2022 - nature.com
The application of next-generation sequencing to study congenital heart disease (CHD) is
increasingly providing new insights into the causes and mechanisms of this prevalent birth …

22q11. 2 deletion syndrome

DM McDonald-McGinn, KE Sullivan, B Marino… - Nature reviews Disease …, 2015 - nature.com
Abstract 22q11. 2 deletion syndrome (22q11. 2DS) is the most common chromosomal
microdeletion disorder, estimated to result mainly from de novo non-homologous meiotic …

[HTML][HTML] Updated clinical practice recommendations for managing children with 22q11. 2 deletion syndrome

S Oskarsdottir, E Boot, TB Crowley, JCY Loo… - Genetics in …, 2023 - Elsevier
This review aimed to update the clinical practice guidelines for managing children and
adolescents with 22q11. 2 deletion syndrome (22q11. 2DS). The 22q11. 2 Society, the …

[图书][B] Moss & Adams' heart disease in infants, children, and adolescents: including the fetus and young adult

HD Allen, DJ Driscoll, RE Shaddy, TF Feltes - 2013 - books.google.com
This 8th Edition of Moss and Adams' Heart Disease in Infants, Children, and Adolescents:
Including the Fetus and Young Adult, provides updated and useful information from leading …

22q11. 2 deletion syndrome and congenital heart disease

E Goldmuntz - American Journal of Medical Genetics Part C …, 2020 - Wiley Online Library
Abstract The 22q11. 2 deletion syndrome has an estimated prevalence of 1 in 4–6,000
livebirths. The phenotype varies widely; the most common features include: facial …

Congenital heart diseases and cardiovascular abnormalities in 22q11. 2 deletion syndrome: from well‐established knowledge to new frontiers

M Unolt, P Versacci, S Anaclerio… - American journal of …, 2018 - Wiley Online Library
Congenital heart diseases (CHDs) and cardiovascular abnormalities are one of the pillars of
clinical diagnosis of 22q11. 2 deletion syndrome (22q11. 2DS) and still represent the main …

De novo damaging variants, clinical phenotypes, and post-operative outcomes in congenital heart disease

MT Boskovski, J Homsy, M Nathan… - Circulation: Genomic …, 2020 - Am Heart Assoc
Background: De novo genic and copy number variants are enriched in patients with
congenital heart disease, particularly those with extra-cardiac anomalies. The impact of de …

Trends in pulmonary valve replacement in children and adults with tetralogy of fallot

ML O'Byrne, AC Glatz, L Mercer-Rosa… - The American journal of …, 2015 - Elsevier
Operative correction of tetralogy of Fallot frequently results in pulmonary insufficiency and
chronic volume overload, which have been linked to increased risk for adverse outcomes …

Prevalence of noncardiac and genetic abnormalities in neonates undergoing cardiac operations: analysis of the society of thoracic surgeons congenital heart surgery …

A Patel, JM Costello, CL Backer, SK Pasquali… - The Annals of thoracic …, 2016 - Elsevier
Background Among patients with congenital heart disease (CHD), the coexistence of
noncardiac congenital anatomic abnormalities (NC), genetic abnormalities (GA), and …

The importance of copy number variation in congenital heart disease

G Costain, CK Silversides, AS Bassett - NPJ genomic medicine, 2016 - nature.com
Congenital heart disease (CHD) is the most common class of major malformations in
humans. The historical association with large chromosomal abnormalities foreshadowed the …